Д.Уранчимэг
Loading...
Товч нэр
Д.Уранчимэг
Бүтэн нэр
Даваацэрэн Уранчимэг
Латин нэр
Davaatseren Uranchimeg
Эрдмийн цол
Профессор
Харьяалал
ORCID
Scopus Author ID
5 results
Now showing 1 - 5 of 5
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Efficacy of Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration(Mongolian National University of Medical Sciences, 2022-12-29); ; ; ;Baasankhuu JamianjavObjective: To study the effect of cataract surgery with intravitreal bevacizumab therapy on visual and anatomical outcomes in patients with neovascular age-related macular degeneration (AMD) in Mongolian patients. Methods: A retrospective analysis of 72 eyes of 36 patients with neovascular AMD evaluated intravitreal bevacizumab (1or2.5 mg) injections. Retreatment was performed following an optical coherence tomography (OCT)-based regimen. Ophthalmic examination included best-corrected visual acuity (BCVA), dilated fundus examination, and OCT image analysis. Results: A total of 11 patients received cataract surgery. We could not observe statistical significance between the two groups. The BCVA of the right eye of patients having cataract surgery improved by 0.21 ± 0.29, while the corresponding value for patients without surgery was 0.32 ± 0.32. The mean central retinal thickness (CRT) of patients with refraction was decreased from 264.4 ± 82.32 μm at baseline to 244.55 ± 52.59 μm for the right eye, while it was 275.4 ± 96.4 μm at baseline to 276.36 ± 68.22 μm for the left eye. Conclusion: Cataract surgery with intravitreal bevacizumab therapy in eyes with neovascular AMD in aged patients was performed. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, One-Year Vision Outcomes of Age-Related Macular Degeneration in Mongolians(Mongolian National University of Medical Sciences, 2024-03-06); ; ; Objectives: To assess the post-treatment vision outcomes in Mongolian patients with age-related macular degeneration. Methods: Surveys assessed subjects' antioxidant intake, age, gender, race, body mass index, hypertension, smoking habits, and sunlight exposure. Results: There were 136 cases and 100 controls, of whom 130 (55.1%) were female. Of the cases, 100 individuals had the dry type of AMD, while 36 participants had the wet type of AMD. The mean ages of the dry and wet AMD groups and controls were 75.33 ± 6.98 years, 76.0 ± 5.57 years, and 67.03 ± 7.14 years, respectively-the change of central retinal thickness and intraocular pressure by month. Our current study found that the central retinal thickness of the dry AMD group did not decrease compared to the baseline. However, the value decreased from 269.9 ± 89.17 (baseline) to 218.33 ± 41.35 at the 3-month follow-up. Concerning the intraocular pressure of all subjects, the baseline pressure of the dry AMD group was 13.88 ± 3.02, and the value was increased to 14.28 ± 2.27 after one year of treatment. In the wet AMD group, the baseline value was 14.06 ± 3.58, rising to 14.42 ± 3.51 at one-year follow-up. Conclusion: A larger sample may produce different and better results. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The polymorphisms of TSHR and CTLA-4 genes as genetic predictors of susceptibility to Graves` ophthalmopathy(Informa UK Limited, 2026-04); ; ; ; PURPOSE: To determine the genetic polymorphisms of CTLA-4 and TSHR genes with susceptibility to Graves` ophthalmopathy among patients with Graves' disease. METHODS: A total of 187 patients with Graves' disease were divided into two groups: 87 with Graves` ophthalmopathy and 100 without. Clinical examination and thyroid function tests were performed for all patients with Graves` disease. The genotyping was performed by restriction fragment length polymorphism and allele-specific PCR methods. RESULTS: rs5742909 T and rs1054708 T alleles were frequent in the group with Graves` ophthalmopathy. By genotypic comparison, the T/T and C/T genotypes of rs5742909 and the T/T genotype of rs1054708 were significantly higher among patients with Graves` ophthalmopathy. In addition, we found more than additive interaction between rs5742909 and rs1054708 (RERI = 3.787, AP = 0.122, S = 1.16), and the patients who carrying T/T or C/T of rs5742909 and T/T of rs1054708 had significantly higher risk of Graves` ophthalmopathy (aOR = 8.77, 95% CI = 3.02-25.52; Power = 98.1%). CONCLUSIONS: This result indicates that rs5742909 of CTLA-4 and rs1054708 of TSHR genes are the genetic risk factors for Graves` ophthalmopathy. In addition, the combination of these polymorphisms might be used as genetic predictors of Graves' ophthalmopathy. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians(Public Library of Science (PLoS), 2022); ; ;Das, Sima; Graves' ophthalmopathy (GO) is a complex inflammatory condition affecting the orbit and is often associated with Graves' disease (GD). This study aims to determine the levels of thyroid-stimulating immunoglobulin (TSI) and thyroid-stimulating hormone receptor autoantibody (TSHR-ab) in the serum of patients with GO, compare it with the GD, and determine whether there is a correlation with the clinical course of GO. The cross-sectional study included 82 patients with GO, 81 patients with GD, and 75 healthy subjects. The ocular manifestations of GO were identified and evaluated by the clinical activity score (CAS) and severity of GO using the European Group of Graves' Orbitopathy (EUGOGO). TSI and TSHR-ab levels in the serum of participants were determined with ELISA kits and correlated with clinical findings. A total of 238 participant's data were analyzed. There were 14 patients (17%) with unilateral GO. The most common ocular signs were eyelid retraction 68 (82.3%) and proptosis 61 (74.4%). The mean CAS score was 2.65±1.64 in GO patients and was higher in men than women (P = 0.008). The mean of TSI was 37.95±35.41 in GO, 14.16±15.67 in GD, and 4.33±2.94 in healthy controls (P<0.0001). The TSI was significantly higher in patients with GO than in those with GD (P<0.0001). There were no correlations between TSI and TSHR-ab levels and CAS scores. However, we observed a correlation between the TSI level and the severity of GO (P = 0.023). The area under the ROC curve (AUC) of TSI was 0.933 and selected 14.1 IU/ml was the optimal cutoff value (98.78% of sensitivity, 83.97% of specificity). Our study showed that TSI is significantly related to GO and the severity of GO. Therefore, TSI can be used as a predictor of severe GO to help in prognostication, follow-up and treatment planning.Scopus© Citations 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 2
